AZN as reported
- Op Margin
- 26%
Op Margin · trailing twelve months to Q2 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross Margin | 83% | n/a | Q2 2025 |
| Op Margin | 26% | n/a | Q2 2025 |
| Net Margin | 19% | n/a | Q2 2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
AstraZeneca PLC (AZN) - Revenue & ProfitRevenue & ProfitAstraZeneca PLC (AZN)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Drug Manufacturers - General
Ranks #3 of 16 by Smart Score